{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:02:28Z","timestamp":1789052548642,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72404098"],"award-info":[{"award-number":["72404098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social Science Foundation of Hubei Province","award":["HBSKJJ20243236"],"award-info":[{"award-number":["HBSKJJ20243236"]}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20240534"],"award-info":[{"award-number":["GZC20240534"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Res Policy Sys"],"DOI":"10.1186\/s12961-024-01250-3","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T02:12:19Z","timestamp":1733105539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased consumption of cardiovascular drugs under volume-based procurement (VBP) policy: demand release or assessment inducing?"],"prefix":"10.1186","volume":"22","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisheng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaotang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"1250_CR1","unstructured":"World Health Organization. Invisible numbers: the true extent of noncommunicable diseases and what to do about them. https:\/\/iris.who.int\/bitstream\/handle\/10665\/362800\/9789240057661-eng.pdf?sequence=1. Accessed 20 Mar 2024."},{"key":"1250_CR2","unstructured":"Disease Control and Prevention Bureau. Progress in disease prevention and control in China. http:\/\/www.nhc.gov.cn\/jkj\/s7915v\/201504\/d5f3f871e02e4d6e912def7ced719353.shtml. Accessed 20 Mar 2024."},{"issue":"38","key":"1250_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3969\/j.issn.10003614.2023.06.001","volume":"2023","author":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China","year":"2022","unstructured":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China. an updated summary. Chin Circ J. 2022;2023(38):583\u2013612. https:\/\/doi.org\/10.3969\/j.issn.10003614.2023.06.001.","journal-title":"Chin Circ J"},{"key":"1250_CR4","unstructured":"National Health Commission. Notice on issuing the \u201c14th Five-Year Plan\u201d for healthy aging. http:\/\/www.nhc.gov.cn\/lljks\/pqt\/202203\/c51403dce9f24f5882abe13962732919.shtml. Accessed 20 Mar 2024."},{"key":"1250_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.11915\/j.issn.1671-5403.2018.11.185","volume":"17","author":"F Cao","year":"2018","unstructured":"Cao F, Wang Y, Xue W, Liu H, Lin X, Li T, et\u00a0al. Clinical multi-centers report of chronic diseases among elderly inpatients in China. Chin J Mult Organ Dis Elderly. 2018;17:801\u20138. https:\/\/doi.org\/10.11915\/j.issn.1671-5403.2018.11.185.","journal-title":"Chin J Mult Organ Dis Elderly"},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.19939\/j.cnki.1672-2809.2023.06.29","volume":"20","author":"W Chen","year":"2023","unstructured":"Chen W, Fang Q, Li Z. Investigation and countermeasures on the status quo of home medication for elderly patients with chronic diseases. Drug Evaluat. 2023;20:758\u201361. https:\/\/doi.org\/10.19939\/j.cnki.1672-2809.2023.06.29.","journal-title":"Drug Evaluat"},{"key":"1250_CR7","first-page":"597","volume":"29","author":"G Zhang","year":"2023","unstructured":"Zhang G, Zhao S, Wang H, Ye Q. Analysis of antihypertensive drug use and hypertension complications in a community health service center in Hangzhou. Chin J Drug Abuse Prevent Treatment. 2023;29:597\u2013600605.","journal-title":"Chin J Drug Abuse Prevent Treatment"},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.16439\/j.issn.1673-7245.2022.07.013","volume":"30","author":"H Zhou","year":"2022","unstructured":"Zhou H, Wang X, Yang Y, Zhang L, Chen Z, Li S, et\u00a0al. Current status on the use of antihypertensive drugs in community outpatient with hypertension in China. Chin J Hypertension. 2022;30:670\u20135. https:\/\/doi.org\/10.16439\/j.issn.1673-7245.2022.07.013.","journal-title":"Chin J Hypertension"},{"key":"1250_CR9","unstructured":"General Office of the State Council. Notice on issuing the pilot plan of national centralized drug procurement and use. https:\/\/www.gov.cn\/gongbao\/content\/2019\/content_5361793.htm. Accessed 20 Mar 2024."},{"key":"1250_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011535","volume":"8","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Wang Q, Sun Q, Lexchin J, Yang L. Improving access to medicines and beyond: the national volume-based procurement policy in China. BMJ Glob Health. 2023;8: e011535. https:\/\/doi.org\/10.1136\/bmjgh-2022-011535.","journal-title":"BMJ Glob Health"},{"key":"1250_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005519","volume":"6","author":"J Yuan","year":"2021","unstructured":"Yuan J, Lu ZK, Xiong X, Jiang B. Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China. BMJ Glob Health. 2021;6: e005519. https:\/\/doi.org\/10.1136\/bmjgh-2021-005519.","journal-title":"BMJ Glob Health"},{"key":"1250_CR12","first-page":"67","volume-title":"Annual report on China\u2019s internet healthcare development (2022\u20132023)","author":"Y Yang","year":"2023","unstructured":"Yang Y, Mao Z. Healthcare big data and pharmaceutical policy evaluation: national volume-based drug procurement policy as an example. In: Mao Z, editor. Annual report on China\u2019s internet healthcare development (2022\u20132023). Beijing: Social Sciences Academic Press; 2023. p. 67\u201385."},{"issue":"12","key":"1250_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3969\/j.issn.1674-2982.2023.12.006","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu Y, Mao J, Mao Z. The impact of centralized volume-based procurement policy on the pharmaceutical industry: review based on the SCP paradigm. Chin J Health Policy. 2024;16(12):40\u20138. https:\/\/doi.org\/10.3969\/j.issn.1674-2982.2023.12.006.","journal-title":"Chin J Health Policy"},{"key":"1250_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054346","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Yang Y, Xu L, Shen Y, Wen X, Mao L, et\u00a0al. Impact of \u201c4+7\u201d volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China. BMJ Open. 2022;12: e054346. https:\/\/doi.org\/10.1136\/bmjopen-2021-054346.","journal-title":"BMJ Open"},{"key":"1250_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.944540","volume":"13","author":"H Long","year":"2022","unstructured":"Long H, Yang Y, Geng X, Mao Z, Mao Z. Changing characteristics of pharmaceutical prices in China under centralized procurement policy: a multi-intervention interrupted time series. Front Pharmacol. 2022;13: 944540. https:\/\/doi.org\/10.3389\/fphar.2022.944540.","journal-title":"Front Pharmacol"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1186\/s12913-021-07143-3","volume":"21","author":"Y Yang","year":"2021","unstructured":"Yang Y, Tong R, Yin S, Mao L, Xu L, Hao S, et\u00a0al. The impact of \u201c4+7\u201d volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis. BMC Health Serv Res. 2021;21:1275. https:\/\/doi.org\/10.1186\/s12913-021-07143-3.","journal-title":"BMC Health Serv Res"},{"key":"1250_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.19546\/j.issn.1674-3830.2024.9.008","volume":"09","author":"Y Yang","year":"2024","unstructured":"Yang Y, Cui D, Mao Z. Analysis on the theory and practice of centralized volume-based drug procurement system in China. China Health Ins. 2024;09:57\u201363. https:\/\/doi.org\/10.19546\/j.issn.1674-3830.2024.9.008.","journal-title":"China Health Ins"},{"key":"1250_CR18","first-page":"13","volume":"41","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhou N, Han W, Wu M. Analysis on the impacts of impacts of the national volume-based procurement policy on drug utilization and drug expenditure. Chin Health Econ. 2022;41:13\u20138.","journal-title":"Chin Health Econ"},{"key":"1250_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.923209","volume":"13","author":"J Lu","year":"2022","unstructured":"Lu J, Long H, Shen Y, Wang J, Geng X, Yang Y, et\u00a0al. The change of drug utilization in China\u2019s public healthcare institutions under the \u201c4+7\u201d centralized drug procurement policy: evidence from a natural experiment in China. Front Pharmacol. 2022;13: 923209. https:\/\/doi.org\/10.3389\/fphar.2022.923209.","journal-title":"Front Pharmacol"},{"key":"1250_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5246\/jcps.2022.03.019","volume":"31","author":"N Luo","year":"2022","unstructured":"Luo N, Yue J, Zhou R, Jiang B. The effects of the National Drug Pooled Procurement (NDPP) pilot program in China. J Chin Pharm Sci. 2022;31:212\u20137. https:\/\/doi.org\/10.5246\/jcps.2022.03.019.","journal-title":"J Chin Pharm Sci"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3969\/j.issn.1674-2982.2023.02.008","volume":"16","author":"W Sun","year":"2023","unstructured":"Sun W, Zhao Z, Cheng Z, Li H, Zhu H. A systematic review on the impact of the volume-based procurement policy on prices and dosages of drugs. Chin J Health Policy. 2023;16:52\u20138. https:\/\/doi.org\/10.3969\/j.issn.1674-2982.2023.02.008.","journal-title":"Chin J Health Policy"},{"key":"1250_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.13723\/j.yxysh.2023.03.022","volume":"36","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang L. Systematic evaluation of the implementation effect of China\u2019s national centralized drug procurement policy. Med Soc. 2023;36:119\u201324. https:\/\/doi.org\/10.13723\/j.yxysh.2023.03.022.","journal-title":"Med Soc"},{"key":"1250_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3969\/j.issn.1008-6390.2022.03.005","volume":"35","author":"X Luo","year":"2022","unstructured":"Luo X, Luo M. Analysis of the use of hypertension drugs before and after the volume-based procurement policy in Chongqing. J Chongqing Univ Educ. 2022;35:30\u20134. https:\/\/doi.org\/10.3969\/j.issn.1008-6390.2022.03.005.","journal-title":"J Chongqing Univ Educ"},{"key":"1250_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.19939\/j.cnki.1672-2809.2022.09.01","volume":"19","author":"A Wei","year":"2022","unstructured":"Wei A, Chen S, Li J, Gong X. Analysis of the influence of drug centralized procurement program on the utilization of cardiovascular drugs in a tertiary hospital. Drug Evaluat. 2022;19:513\u20136. https:\/\/doi.org\/10.19939\/j.cnki.1672-2809.2022.09.01.","journal-title":"Drug Evaluat"},{"key":"1250_CR25","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.7539\/j.issn.1672-2981.2022.12.036","volume":"20","author":"N Zhang","year":"2022","unstructured":"Zhang N, Ma H, Qian Q, Wang M, Zhang F. Use of cardiovascular drugs in a hospital in Nanjing under national centralized purchase. Central South Pharm. 2022;20:2920\u20134. https:\/\/doi.org\/10.7539\/j.issn.1672-2981.2022.12.036.","journal-title":"Central South Pharm"},{"key":"1250_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3969\/j.issn.1006-5253.2022.05.013","volume":"29","author":"Q Li","year":"2022","unstructured":"Li Q, Wan J, Jiao S, Liu G, Zhao S, Wang X. Impact of volume-based purchasing policy on the use of branded and generic cardiovascular drugs in a hospital. Chin J Hos Stat. 2022;29:377\u2013382387. https:\/\/doi.org\/10.3969\/j.issn.1006-5253.2022.05.013.","journal-title":"Chin J Hos Stat"},{"key":"1250_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.15975\/j.cnki.gsyy.2022.11.010","volume":"41","author":"C Liu","year":"2022","unstructured":"Liu C. The impact of \u201c4+7\u201d volume-based procurement on the use of hospital cardiovascular drugs. Gansu Med J. 2022;41:1021\u20133. https:\/\/doi.org\/10.15975\/j.cnki.gsyy.2022.11.010.","journal-title":"Gansu Med J"},{"key":"1250_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.13688\/j.cnki.chr.2022.220715","volume":"25","author":"M Chen","year":"2022","unstructured":"Chen M, Xie J, Wang B, Wang W, Shao R. Study on the policy effect differences of volume-based procurement policy in different level of hospitals in Changzhou city. Chin Health Res. 2022;25:765\u20139+779. https:\/\/doi.org\/10.13688\/j.cnki.chr.2022.220715.","journal-title":"Chin Health Res"},{"key":"1250_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.688069","volume":"12","author":"M Zhao","year":"2021","unstructured":"Zhao M, Nie P, Wu J. Heterogeneity in price elasticity of medicine demand in China: moderate effect from economic incentive and quality difference. Front Pharmacol. 2021;12: 688069. https:\/\/doi.org\/10.3389\/fphar.2021.688069.","journal-title":"Front Pharmacol"},{"key":"1250_CR30","unstructured":"National Healthcare Security Administration. Opinions on the supporting measures of medical insurance on the pilot program of national centralized drug procurement and use. http:\/\/www.nhsa.gov.cn\/art\/2019\/3\/5\/art_53_1016.html?eqid=9a40f0e800096a04000000036430cf0d. Accessed 20 Mar 2024."},{"key":"1250_CR31","unstructured":"National Health Commission. Notice on the clinical equipment and use of the bid-winning drugs in the national centralized drug procurement. http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201901\/628ac5004d244af7ad53c0b109f0c2df.shtml. Accessed 20 Mar 2024."},{"key":"1250_CR32","unstructured":"National Health Commission. Notice on further improving the clinical equipment and use of the bid-winning drugs in the national centralized drug procurement. http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201912\/7b1639fb14ca4cd59cd33f367455d92d.shtml. Accessed 20 Mar 2024."},{"key":"1250_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.19546\/j.issn.1674-3830.2022.4.006","volume":"4","author":"P Xiao","year":"2022","unstructured":"Xiao P, Tian D. Implementation and suggestions for centralized drug procurement in public hospitals\u2014taking a level III hospital in Hubei province as an example. China Health Insurance. 2022;4:33\u20136. https:\/\/doi.org\/10.19546\/j.issn.1674-3830.2022.4.006.","journal-title":"China Health Insurance"},{"key":"1250_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15887\/j.cnki.13-1389\/r.2021.16.071","volume":"14","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu T, Xu W, Wang Y. Analysis on the clinical application of the first batch of volume-based procured drugs. Chin J Clin Rational Drug Use. 2021;14:163\u20135. https:\/\/doi.org\/10.15887\/j.cnki.13-1389\/r.2021.16.071.","journal-title":"Chin J Clin Rational Drug Use"},{"key":"1250_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12913-021-06698-5","volume":"21","author":"Y Yang","year":"2021","unstructured":"Yang Y, Chen L, Ke X, Mao Z, Zheng B. The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018\u20132019: an interrupted time-series analysis. BMC Health Serv Res. 2021;21:668. https:\/\/doi.org\/10.1186\/s12913-021-06698-5.","journal-title":"BMC Health Serv Res"},{"key":"1250_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.13664\/j.cnki.pcr.2023.04.013","volume":"31","author":"J Guo","year":"2023","unstructured":"Guo J, Chen D, Zhang H. Changes in the use and cost of oral antimicrobials related to centralized volume-based procurement policy: an interrupted time-series analysis. Pharm Clin Res. 2023;31:374\u20139. https:\/\/doi.org\/10.13664\/j.cnki.pcr.2023.04.013.","journal-title":"Pharm Clin Res"},{"key":"1250_CR37","unstructured":"General Office of the State Council. Opinions on promoting the normalization and institutionalization of centralized volume-based drug procurement. https:\/\/www.gov.cn\/zhengce\/content\/2021-01\/28\/content_5583305.htm. Accessed 20 Mar 2024."},{"issue":"5","key":"1250_CR38","first-page":"3","volume":"34","author":"L Tao","year":"2020","unstructured":"Tao L. Economics analysis on bulk-cheap purchasing mechanism in group procurement of medicine. Soft Sci Health. 2020;34(5):3\u20135.","journal-title":"Soft Sci Health"},{"key":"1250_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14055\/j.cnki.331056\/f.2021.06.036","volume":"38","author":"C Jiang","year":"2021","unstructured":"Jiang C, Zhang L, Qi P, Li X. Analysis on some economic principles of volume-based procurement. Health Econ Res. 2021;38:63\u20135. https:\/\/doi.org\/10.14055\/j.cnki.331056\/f.2021.06.036.","journal-title":"Health Econ Res"},{"key":"1250_CR40","unstructured":"General Office of the State Council. Opinions on strengthening the performance appraisal of tertiary public hospitals. https:\/\/www.gov.cn\/zhengce\/content\/2019-01\/30\/content_5362266.htm. Accessed 20 Mar 2024."},{"key":"1250_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.19435\/j.1672-1721.2023.07.037","volume":"27","author":"Y Liu","year":"2023","unstructured":"Liu Y, Cao Q. Interpretation, implementation process, and discussion of national volume-based drug procurement surplus retention policy: taking Shanxi province as an example. Med Forum. 2023;27:116\u20139. https:\/\/doi.org\/10.19435\/j.1672-1721.2023.07.037.","journal-title":"Med Forum"},{"key":"1250_CR42","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.socscimed.2012.05.044","volume":"75","author":"M Huff-Rousselle","year":"2012","unstructured":"Huff-Rousselle M. The logical underpinnings and benefits of pooled pharmaceutical procurement: a pragmatic role for our public institutions? Soc Sci Med. 2012;75:1572\u201380. https:\/\/doi.org\/10.1016\/j.socscimed.2012.05.044.","journal-title":"Soc Sci Med"},{"key":"1250_CR43","unstructured":"National Healthcare Security Administration, 2023. The State Council Information Office held a themed press conferences on the \u201cthe authoritative departments speck opening\u201d. http:\/\/www.nhsa.gov.cn\/art\/2023\/5\/18\/art_14_10627.html. Accessed 20 Mar 2024."},{"issue":"04","key":"1250_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3969\/j.issn.16742982.2023.05.005","volume":"16","author":"B Wang","year":"2023","unstructured":"Wang B, Zhang T, Tang X, Jia Y, Luo L. Research on differences and regional distributions of selected-drug prices involved in China\u2019s centralized quantity-based procurement. Chin J Health Pol. 2023;16(04):32\u20136. https:\/\/doi.org\/10.3969\/j.issn.16742982.2023.05.005.","journal-title":"Chin J Health Pol"},{"issue":"01","key":"1250_CR45","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1186\/s12889-021-11882-7","volume":"21","author":"N Wang","year":"2021","unstructured":"Wang N, Yang Y, Xu L, Mao Z, Cui D. Influence of Chinese national centralized drug procurement on the price of policy-related drugs: an interrupted time series analysis. BMC Public Health. 2021;21(01):1883. https:\/\/doi.org\/10.1186\/s12889-021-11882-7.","journal-title":"BMC Public Health"},{"key":"1250_CR46","volume-title":"Principles of economics: microeconomics section","author":"NG Mankiw","year":"2012","unstructured":"Mankiw NG. Principles of economics: microeconomics section. 6th ed. Beijing: Peking University Press; 2012.","edition":"6"},{"key":"1250_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3969\/j.issn.1001-0408.2006.09.002","volume":"17","author":"H Zhu","year":"2006","unstructured":"Zhu H, Gu H. Analyze the drug elasticity of demand of urban residents through ELES model. China Pharmacy. 2006;17:651\u20133. https:\/\/doi.org\/10.3969\/j.issn.1001-0408.2006.09.002.","journal-title":"China Pharmacy"},{"key":"1250_CR48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.16439\/j.cnki.1673-7245.2017.10.017","volume":"25","author":"J Nie","year":"2017","unstructured":"Nie J, Zhang L, Chen Z, Wang X, Guo M, Tian Y, et\u00a0al. The status of the use of antihypertensive agents in hypertensive patients in the community. Chin J Hypertension. 2017;25:956\u201360. https:\/\/doi.org\/10.16439\/j.cnki.1673-7245.2017.10.017.","journal-title":"Chin J Hypertension"},{"key":"1250_CR49","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3870\/j.issn.1004-0781.2023.10.009","volume":"42","author":"Y Zou","year":"2023","unstructured":"Zou Y, Dong W, Mao J, Lin Y, Liang X. A cross-sectional survey on affordability of original and generic antihypertensive drugs before and after national centralized procurement in Shaanxi province. Herald Med. 2023;42:1473\u20138. https:\/\/doi.org\/10.3870\/j.issn.1004-0781.2023.10.009.","journal-title":"Herald Med"},{"key":"1250_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3969\/j.issn.16735625.2022.01.003","volume":"39","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Chen X. The influence of healthcare policy on doctors\u2019 prescription behavior. Chin J Soc Med. 2022;39:7\u201310. https:\/\/doi.org\/10.3969\/j.issn.16735625.2022.01.003.","journal-title":"Chin J Soc Med"},{"key":"1250_CR51","doi-asserted-by":"publisher","unstructured":"Zeng Q. Study on the implementation of medical insurance drug procurement with target quantity policy in Sichuan province. Chengdu: Southwestern University of Finance and Economics, 2022. https:\/\/doi.org\/10.27412\/d.cnki.gxncu.2022.002966","DOI":"10.27412\/d.cnki.gxncu.2022.002966"},{"key":"1250_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.813213","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Geng X, Liu X, Wen X, Wu R, Cui D, et\u00a0al. Antibiotic use in China\u2019s public healthcare institutions during the COVID-19 pandemic: an analysis of nationwide procurement data, 2018\u20132020. Front Pharmacol. 2022;13: 813213. https:\/\/doi.org\/10.3389\/fphar.2022.813213.","journal-title":"Front Pharmacol"},{"key":"1250_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3969\/j.issn.1674-9316.2016.01.004","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Wang C. Study the correlation of Dezhou\u2019s economic development and drug in hyperlipidemia. Chin Health Standard Manage. 2016;7:5\u20137. https:\/\/doi.org\/10.3969\/j.issn.1674-9316.2016.01.004.","journal-title":"Chin Health Standard Manage"},{"key":"1250_CR54","first-page":"562","volume":"36","author":"S Tang","year":"2019","unstructured":"Tang S, Yang D. Research on the relationship between drug costs, social health expenditures, and per capita disposable income. Chin J Health Stat. 2019;36:562\u20134+567.","journal-title":"Chin J Health Stat"},{"key":"1250_CR55","unstructured":"National Bureau of Statistics, 2021. Which indicator is more reasonable to reflect the income level of residents? http:\/\/www.stats.gov.cn\/zt_18555\/zthd\/sjtjr\/d12kfr\/tjzsqzs\/202302\/t20230216_1908890.html. Accessed 20 Mar 2024."},{"key":"1250_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.19313\/j.cnki.cn10-1223\/f.20211227.002","volume":"2","author":"W Huang","year":"2022","unstructured":"Huang W, Zhang Z, Liu A. From difference-in-differences to event study. Rev Ind Econ. 2022;2:17\u201336. https:\/\/doi.org\/10.19313\/j.cnki.cn10-1223\/f.20211227.002.","journal-title":"Rev Ind Econ"},{"key":"1250_CR57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/qje\/qjr009","volume":"126","author":"N Nunn","year":"2011","unstructured":"Nunn N, Qian N. The potato\u2019s contribution to population and urbanization: evidence from a historical experiment. Q J Econ. 2011;126:593\u2013650. https:\/\/doi.org\/10.1093\/qje\/qjr009.","journal-title":"Q J Econ"},{"key":"1250_CR58","doi-asserted-by":"publisher","first-page":"9415","DOI":"10.3390\/ijerph17249415","volume":"17","author":"L Chen","year":"2020","unstructured":"Chen L, Yang Y, Luo M, Hu B, Yin S, Mao Z. The Impacts of national centralized drug procurement policy on drug utilization and drug expenditures: the case of Shenzhen, China. Int J Environ Res Public Health. 2020;17:9415. https:\/\/doi.org\/10.3390\/ijerph17249415.","journal-title":"Int J Environ Res Public Health"},{"key":"1250_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3969\/j.issn.1674-361X.2023.03.011","volume":"15","author":"J Chen","year":"2023","unstructured":"Chen J, Chi L, Ye Q, Wei X, Yan C. The influence of national volume-based procurement of drugs on chronic disease management in community health service centers. China Rural Health. 2023;15:38\u20139+42. https:\/\/doi.org\/10.3969\/j.issn.1674-361X.2023.03.011.","journal-title":"China Rural Health"},{"key":"1250_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/cer.14.28","volume":"3","author":"W Zeng","year":"2014","unstructured":"Zeng W, Zhen J, Feng M, Campbell SM, Finlayson AE, Godman B. Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction. J Comp Eff Res. 2014;3:371\u201386. https:\/\/doi.org\/10.2217\/cer.14.28.","journal-title":"J Comp Eff Res"},{"key":"1250_CR61","first-page":"354","volume":"35","author":"P Liu","year":"2018","unstructured":"Liu P, Wang F, Su L, Yao W. A study on the formation mechanism of \u201cgifenization\u201d phenomenon in pharmaceutical market in Chinese public hospitals. Chin Health Service Manage. 2018;35:354\u2013356364.","journal-title":"Chin Health Service Manage"},{"key":"1250_CR62","volume-title":"The Impact of centralized volume-based drug procurement policy on drug prices and expenditures in China: from the perspective of strategic purchasing","author":"Y Yang","year":"2022","unstructured":"Yang Y. The Impact of centralized volume-based drug procurement policy on drug prices and expenditures in China: from the perspective of strategic purchasing. Wuhan: Wuhan University; 2022."},{"key":"1250_CR63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/1475-6773.13289","volume":"55","author":"JC Maclean","year":"2020","unstructured":"Maclean JC, Halpern MT, Hill SC, Pesko MF. The effect of Medicaid expansion on prescriptions for breast cancer hormonal therapy medications. Health Serv Res. 2020;55:399\u2013410. https:\/\/doi.org\/10.1111\/1475-6773.13289.","journal-title":"Health Serv Res"},{"key":"1250_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhealeco.2018.11.002","volume":"63","author":"A Ghosh","year":"2019","unstructured":"Ghosh A, Simon K, Sommers BD. The effect of health insurance on prescription drug use among low-Income adults: evidence from recent medicaid expansions. J Health Econ. 2019;63:64\u201380. https:\/\/doi.org\/10.1016\/j.jhealeco.2018.11.002.","journal-title":"J Health Econ"},{"key":"1250_CR65","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.14756773.2006.00659.x","volume":"42","author":"DG Shea","year":"2007","unstructured":"Shea DG, Terza JV, Stuart BC, Briesacher B. Estimating the effects of prescription drug coverage for Medicare beneficiaries. Health Serv Res. 2007;42:933\u201349. https:\/\/doi.org\/10.1111\/j.14756773.2006.00659.x.","journal-title":"Health Serv Res"},{"key":"1250_CR66","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12888-024-06026-1","volume":"24","author":"J Wu","year":"2024","unstructured":"Wu J, Qiu L, Li J, Zhou Q, Xie W, Shen Y. Choice intention for the national volume-based procurement drug and its associated factors: a cross-sectional study on patients with late-life depression in China. BMC Psychiatry. 2024;24:580. https:\/\/doi.org\/10.1186\/s12888-024-06026-1.","journal-title":"BMC Psychiatry"},{"key":"1250_CR67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/17535654.2023.2317104","volume":"61","author":"G Zeng","year":"2023","unstructured":"Zeng G, Liu P, Liu Y. Study on hospital choice behavior of elderly patients with chronic diseases in China. China Modern Doctor. 2023;61:88\u201391+115.","journal-title":"China Modern Doctor."},{"key":"1250_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3969\/j.issn.1674-2982.2020.07.010","volume":"13","author":"X Zhang","year":"2020","unstructured":"Zhang X, Jiang X, Zheng J, Peng B, Li Y. Analysis on the availability and allocation of essential drugs for hypertension and diabetes in primary health institutions. China J Health Pol. 2020;13:58\u201365. https:\/\/doi.org\/10.3969\/j.issn.1674-2982.2020.07.010.","journal-title":"China J Health Pol"},{"key":"1250_CR69","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/heapol\/czy076","volume":"33","author":"S Gong","year":"2018","unstructured":"Gong S, Cai H, Ding Y, Li W, Juan X, Peng J, et\u00a0al. The availability, price and affordability of antidiabetic drugs in Hubei province. China Health Policy Plan. 2018;33:937\u201347. https:\/\/doi.org\/10.1093\/heapol\/czy076.","journal-title":"China Health Policy Plan"},{"issue":"06","key":"1250_CR70","doi-asserted-by":"publisher","first-page":"641","DOI":"10.6039\/j.issn.1001-0408.2024.06.01","volume":"35","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wen X, Duan F, Wang Y, Yang Y, Mao Z. Analysis of influential factors for purchasing quantity changes in the procurement varieties of the first batch of drug centralized procurement. China Pharm. 2024;35(06):641\u20136. https:\/\/doi.org\/10.6039\/j.issn.1001-0408.2024.06.01.","journal-title":"China Pharm"},{"key":"1250_CR71","unstructured":"Healthcare Security Administration of Shandong Province. Notice on issuing \u201cthe implementation plan for promoting the use of volume-based procured drugs into the primary healthcare settings in Shandong Province\u201d. http:\/\/ybj.shandong.gov.cn\/art\/2023\/6\/21\/art_65415_10304760.html. Accessed 20 Mar 2024."},{"key":"1250_CR72","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.6039\/j.issn.1001-0408.2023.18.01","volume":"34","author":"H Wang","year":"2023","unstructured":"Wang H, Hup Y, Zhuang Q. Study on essential medicine system from the perspective of coordinated with centralized volume-based procurement policy. China Pharm. 2023;34:2177\u201381. https:\/\/doi.org\/10.6039\/j.issn.1001-0408.2023.18.01.","journal-title":"China Pharm"},{"key":"1250_CR73","first-page":"20","volume":"6","author":"H Gao","year":"2021","unstructured":"Gao H. Foreign enterprises transforming into the retail market. China Drug Store. 2021;6:20\u20131.","journal-title":"China Drug Store"},{"key":"1250_CR74","unstructured":"CN-Healthcare. Hospital is out of stock, the common \u201cstar\u201d drug says \u201cno\u201d to the volume-based procurement. https:\/\/www.cn-healthcare.com\/articlewm\/20230315\/content-1523863.html. Accessed 20 Mar 2024."}],"container-title":["Health Research Policy and Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12961-024-01250-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12961-024-01250-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12961-024-01250-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T03:03:46Z","timestamp":1733108626000},"score":1,"resource":{"primary":{"URL":"https:\/\/health-policy-systems.biomedcentral.com\/articles\/10.1186\/s12961-024-01250-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1186\/s12961-024-01250-3","relation":{},"ISSN":["1478-4505"],"issn-type":[{"value":"1478-4505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}